Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

The Association Between Circulating Inflammatory Markers and Metabolic Syndrome in Korean Rural Adults

  • Ryu, So-Yeon (Department of Preventive Medicine, Chosun University Medical School) ;
  • Kim, Ki-Soon (Department of Preventive Medicine, Chosun University Medical School) ;
  • Park, Jong (Department of Preventive Medicine, Chosun University Medical School) ;
  • Kang, Myeng-Guen (Department of Preventive Medicine, Chosun University Medical School) ;
  • Han, Mi-Ah (Department of Preventive Medicine, Chosun University Medical School)
  • Published : 2008.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was performed to investigate the associations between the metabolic syndrome (MetS) and inflammatory markers. Methods: This cross-sectional analysis was performed using data from 1578 Koreans aged 40-69 years residing in a rural area. We investigated associations between MetS and circulating high sensitivity C-reactive protein (hs-CRP), white blood cells (WBC) and adiponectin. MetS was defined using the criteria proposed by the National Cholesterol Education Program Adult Treatment Panel III (ATP-III). Results: Increased WBC counts and hs-CRP levels and decreased adiponectin levels were observed in subjects with MetS. WBC, hs-CRP and adiponectin levels linearly deteriorated with an increase in the number of MetS components (all ptrend <0.005). Finally, adjusted odds ratios (ORs) for the risk of MetS by increase/decrease in 3 inflammatory markers were calculated by multivariate logistic regression analyses. In terms of changes in inflammation markers, in men, the adjusted ORs (95% confidence interval) were 1.15 (1.01-1.31) for WBC, 1.64 (1.02-2.64) for hs-CRP, and 0.19(0.08-0.45) for adiponectin, whereas corresponding adjusted ORs (95% Cls) in women were 1.27 (1.15-1.40), 0.98 (0.67-1.42), 0.09 (0.04-0.18), respectively. Conclusions: Serum adiponectin levels and WBC counts were found to be strongly associated with MetS in both sexes. However, hs-CRP lost its significance after adjusting for BMI and other inflammatory markers in women. This study shows that inflammatory response is associated with MetS in the Korean population. Further prospective studies are necessary to confirm the contribution made by inflammatory markers to the development of MetS.

Keywords

References

  1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3): 356-359 https://doi.org/10.1001/jama.287.3.356
  2. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji E, et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006; 26(4): 871-876 https://doi.org/10.1161/01.ATV.0000208363.85388.8f
  3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(4): 683-689 https://doi.org/10.2337/diacare.24.4.683
  4. Risk Factor and Life Expectancy Research Group, Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: A populationbased study. Am J Epidemiol 1998; 148(10); 958-966 https://doi.org/10.1093/oxfordjournals.aje.a009572
  5. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112(12): 1785-1788 https://doi.org/10.1172/JCI20514
  6. Gonzaalez AS, Guerrero DB, Soto MB, Diaz SP, Martinez-Olmos A, Vidal O. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 2006; 60(6): 802-809 https://doi.org/10.1038/sj.ejcn.1602384
  7. Lim S, Lee HK, Kimm KC, Park C, Shin C, Cho NH. C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. Diabetes Res Clin Pract 2005; 70(2): 126-133 https://doi.org/10.1016/j.diabres.2005.02.020
  8. Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, et al. Association between elevated liver enzymes and C-reactive protein: Possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2005; 25(1): 193-197
  9. Choi KM, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, et al. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 2007; 75(2): 235-240 https://doi.org/10.1016/j.diabres.2006.06.019
  10. Targher G, Siedell JC, Tonoli M, Muggeo M, De Sandre G, Cigolini M. The white blood cell count: Its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 1996; 239(5): 435-441 https://doi.org/10.1046/j.1365-2796.1996.815000.x
  11. Ford ES. The metabolic syndrome and Creactive protein, fibrinogen, and leukocyte count : Findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003; 168(2): 351-358 https://doi.org/10.1016/S0021-9150(03)00134-5
  12. Desai MY, Dalal D, Santos RD, Carvalho JA, Nasir K, Blumenthal RS. Association of body mass index, metabolic syndrome, and leukocyte count. Am J Cardiol 2006; 97(6): 835-838 https://doi.org/10.1016/j.amjcard.2005.10.021
  13. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Prateley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86(5): 1930-1935 https://doi.org/10.1210/jc.86.5.1930
  14. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, et al. Serum adiponectin concentrations predict the development of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 2004; 61(1): 75-80 https://doi.org/10.1111/j.1365-2265.2004.02063.x
  15. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24(1): 29-33 https://doi.org/10.1161/01.ATV.0000099786.99623.EF
  16. Ryu SY, Kim KS, Park J, Kang MG, Han MA. Serum ferritin and risk of the metabolic syndrome in some Korean rural residents. J Prev Med Public Health 2008; 41(2): 115-120.(Korean) https://doi.org/10.3961/jpmph.2008.41.2.115
  17. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association, et al. Definition fo metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109(3): 433-438
  18. Lee SY, Parak HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007; 75(1): 72-80 https://doi.org/10.1016/j.diabres.2006.04.013
  19. Nakanishi N, Sato M, Shirai K, Nakajima K, Murakami S, Takatoeige T, et al. Associations between white blood cell count and features of the metabolic syndrome in Japanese male office workers. Ind Health 2002; 40(3):273-277 https://doi.org/10.2486/indhealth.40.273
  20. Lohsoonthorn V, Dhanamun B, Williams M. Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am J Hypertens 2006; 19(4): 339-45 https://doi.org/10.1016/j.amjhyper.2005.10.008
  21. Ishizaka N, Ishizaka Y, Toda EI, Nagai R, Koike K, Hashimoto H, et al. Relationship between smoking, white blood cell count and metabolic syndrome in Japanese women. Diabetes Res Clin Pract 2007; 78(1):72-76 https://doi.org/10.1016/j.diabres.2007.02.009
  22. Festa A, D Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102(1): 42-47 https://doi.org/10.1161/01.CIR.102.1.42
  23. Makita S, Nakamura M, Horamori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005; 36(10): 2138-2142 https://doi.org/10.1161/01.STR.0000181740.74005.ee
  24. Blackburn R, Giral P, Bruckert E, Andre JM, Gonbert S, Bernard M, et al. Elevated Creactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 2001; 21(12): 1962-1968 https://doi.org/10.1161/hq1201.099433
  25. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, et al. Association of Creactive protein with caritid atherosclerosis in men and women: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002; 22(10): 1662-1667 https://doi.org/10.1161/01.ATV.0000034543.78801.69
  26. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24(1): 29-33 https://doi.org/10.1161/01.ATV.0000099786.99623.EF
  27. Salas-Salvado J, Granada M, Bullo M, Corominas A, Casas P, Foz M. Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome. Metabolism 2007; 56(11): 1486-1492 https://doi.org/10.1016/j.metabol.2007.06.014
  28. Kumada M, Kihara S, Ouchi N, Kobayashi H, Okamoto Y, Ohashi K, et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109(17): 2046-2049 https://doi.org/10.1161/01.CIR.0000127953.98131.ED
  29. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278(45): 45021-45026 https://doi.org/10.1074/jbc.M307878200
  30. Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 2003; 18(6): 471-478 https://doi.org/10.1097/00001573-200311000-00008

Cited by

  1. Association between insulin resistance and c-reactive protein among Peruvian adults vol.2, pp.None, 2008, https://doi.org/10.1186/1758-5996-2-30
  2. Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells vol.347, pp.1, 2011, https://doi.org/10.1007/s11010-010-0627-y
  3. Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study vol.4, pp.None, 2008, https://doi.org/10.1186/1758-5996-4-28
  4. In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension vol.32, pp.2, 2008, https://doi.org/10.1097/hjh.0000000000000032
  5. Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? vol.15, pp.10, 2008, https://doi.org/10.5152/akd.2014.5787
  6. Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance vol.14, pp.2, 2008, https://doi.org/10.1089/met.2015.0113
  7. Incremental Predictive Value of Serum AST-to-ALT Ratio for Incident Metabolic Syndrome: The ARIRANG Study vol.11, pp.8, 2016, https://doi.org/10.1371/journal.pone.0161304
  8. Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom vol.49, pp.3, 2008, https://doi.org/10.1111/evj.12606
  9. The Relationship between Chronic Rhinosinusitis and Metabolic Syndrome vol.31, pp.4, 2017, https://doi.org/10.2500/ajra.2017.31.4445
  10. Association between C-Reactive Protein and Metabolic Syndrome in Korean Adults vol.40, pp.2, 2019, https://doi.org/10.4082/kjfm.17.0075